President Trump is preparing to nominate former Fed Governor Kevin Warsh to lead the central bank, according to people familiar with the discussions, a move that triggered immediate market reactions as investors assessed the potential policy shift.
A landmark agreement between the U.S. Department of Commerce and the Cameco-Westinghouse joint venture aims to catalyze over $80 billion in new nuclear reactor construction by 2030, bolstering Western energy security and reducing reliance on Russian nuclear fuel.
Brent crude surged above $70 a barrel for the first time since mid-2025, driven by escalating Middle East tensions and shifting supply dynamics, as analysts signal a fading bearish outlook for the oil market.
Major U.S. federal investment to build a domestic rare earth supply chain emerges as a direct competitive threat to Lynas Rare Earths, coinciding with the planned retirement of its long-serving CEO Amanda Lacaze. The developments test the Australian miner's strategic position in a market defined by geopolitical tensions and supply security concerns.
The U.S. dollar's recent plunge to multi-year lows has unsettled markets, fueling debate over the currency's future and the economic policies driving its decline.
Amid market volatility, a detailed analysis circulating among value investors makes a case for Kimberly-Clark Corporation. The thesis highlights the household products maker's resilient business model, technical support levels, and a valuation disconnect that could signal a compelling entry point for long-term portfolios.
Amid rising global tensions and sustained U.S. defense spending, Lockheed Martin's unique role in stitching together America's missile and space defense architecture presents a compelling investment case, analysts argue.
Prestige Consumer Healthcare Inc. (PBH) is drawing investor attention following its $662.5 million acquisition of Stampede Culinary Partners. Analysts see the deal as a catalyst for growth, potentially enhancing earnings and expanding the company's footprint in North America's specialty food sector.
Once left for dead after a 95% stock collapse, Jumia Technologies AG is staging a remarkable comeback. A locally-focused strategy, a vast pickup station network, and a blockbuster Black Friday in Lagos signal the African e-commerce pioneer may finally be on a path to sustainable growth, even as it faces competition from global giants.
Bio-Techne (TECH) gains market attention with the launch of its Cultrex Synthetic Hydrogel, a key innovation for 3D cell research. While the product debut coincides with recent share price strength, longer-term returns tell a more complex story for investors.
SanDisk stock surged over 15% as analysts point to the company's dominant position in supplying high-performance storage for the rapidly expanding AI infrastructure, leading to a dramatic rise in profits and a significantly upgraded price target.
A North Carolina mother, mourning the loss of her daughter and the young woman's boyfriend in a head-on collision, speaks out against what she perceives as a culture of irresponsibility glorified in award shows and a justice system that failed to prevent a preventable tragedy.
An analysis of the bullish investment case for DaVita Inc. highlights its entrenched market position and cash flow discipline, while underscoring the significant regulatory and leverage risks inherent in the kidney care sector.
Despite beating top-line estimates, PepsiCo faces mounting challenges from volume declines and margin compression. With a $4 billion activist stake and new leadership focus, 2025 is poised as a pivotal transition year for the consumer staples titan.
Centrus Energy is transforming its Tennessee facility into a high-volume manufacturing hub for advanced centrifuges, a strategic move aimed at bolstering domestic uranium enrichment capacity and reducing foreign reliance in line with national energy security objectives.
Vaxcyte (PCVX) bolsters its financial position with a successful public offering, channeling fresh capital into pivotal late-stage trials for its broad-spectrum pneumococcal vaccine candidate, VAX-31, in both adults and infants.
Despite a normalized growth phase, HubSpot's consistent execution, expanding profitability, and deepening product adoption among small to mid-sized businesses are building a compelling case for long-term investors, even as direct AI monetization remains on the horizon.
Despite lingering post-pandemic and industry headwinds, Cinemark Holdings (CNK) presents a compelling value case. With a dominant concession model, a massive loyalty program, and a slate of delayed blockbusters on the horizon, analysts see significant upside as the theater chain's financials stabilize and capital returns to shareholders begin.
Havana acknowledges 'communications' with the Trump administration but stops short of confirming talks, as fuel shortages and U.S. pressure push the island toward a humanitarian brink.
A coalition of 22 state attorneys general is urging Congress to expand an investigation into potential ideological influence on the federal judiciary, citing concerns over a newly updated judicial reference manual they claim promotes a climate activist agenda.
